1.Prof.Li Zhihui gave an oral presentation on the theme of"CD7 Chimeric Antigen Receptor T-Cell Therapy Bridging to Allogeneic Hematopoietic Stem Cell Transplantation Remarkably Improved Long-Term Disease-Free Survival in Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma"

2.Prof.Zhao Defeng made a poster display with the theme of"Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia"

3.Prof.Pan Jing made a poster display with the theme of"CAR-T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma:A Retrospective Study"

4.The international multi-center research results"Project Evolve,Evaluation of Lineage Switch(LS),an International Initiative:Preliminary Results Reveal Dismal Outcomes in Patients with LS"were published by Director Pan Jing.

5.Dr.Lin Yuehui was selected as the abstract of the paper on the topic"The Efficacy and Safety of Olverembatinib Combined with Monoclonal Antibodies as Salvage Therapy for RR B ALL with ABL1 Fusion Gene Positive".

6.The research results"Clinical Features and Therapeutic Evaluation of Central Nervous System Involvement in Pediatric Anaplastic Large Cell Lymphoma"participated by Director Zhang Yonghong were selected for oral and poster presentation.

7.The research results"Clinical Pathology Characteristics of 221 Pediatric Anaplastic Large Cell Lymphoma-3 Years Follow up and Experience from China Net Childhood Lymphoma(CNCL)"participated by Director Zhang Yonghong were selected for oral and poster presentation.

8.The research results"Prognostic Impact of Minimal Disseminated Disease(MDD)and Minimal Residual Disease(MRD)in Chinese Pediatric Patients with ALK-K-Positive Anaplastic Large Cell Lymphoma(ALCL)"participated by Director Zhang Yonghong were selected for oral and poster presentation.

9.Dr.Liu Rui made a poster display with the theme of"Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia".

10.Dr.Ma Lixia made a poster display with the theme of"Efficacy and Safety of Autologous Stem Cell Transplantation Combined with Chimeric Antigen Receptor T-Cell Therapy in the Treatment of Refractory/Relapsed B-Cell Lymphoma".

11.Dr.Xu Teng made a poster display with the theme of"Evaluating the Impact of Cryopreservation of PBMCs on CAR-T Therapy Efficacy and Safety in DLBCL Patients:An Informative Approach to Optimize Manufacturing Strategies".

12.Dr.Shi Hui made a poster display with the theme of"The Mini-Teddi-R Treatment Demonstrated a High Rate of Remission in Patients with DLBCL Involving the CNS Who Had Previously Been Exposed to BTK Inhibitors".

13.Dr.Feng Shaomei made a poster display with the theme of"A Compilation of Experiences in Utilizing CAR-T Cell Therapy for Richter’s Transformation".

14.Prof.Yang Fan made a poster display with the theme of"Assessment of Activities of Daily Living(ADL)Scale can be Used to Predict overall Survival after CAR-T cell Therapy in Elderly People(over 70 Years of Age)with Refractory/Relapsed B-Cell Lymphoma".